analytical
sterility testing and usp <71>
what sterility testing measures, how the usp <71> compendial method works, and why sterility is a different question from endotoxin on a peptide coa.
Sterility testing determines whether a sample contains viable microorganisms, and the standard method for it is USP General Chapter <71>, which incubates the material in growth media for 14 days and checks for any growth. It is one of the parameters that may appear on a Certificate of Analysis, and it is frequently confused with endotoxin testing, though the two answer different questions.
This article explains what sterility means analytically, how the compendial test works, and how to interpret its presence or absence on a COA.
what "sterile" actually means
Sterility is the absence of viable (living, able to reproduce) microorganisms: bacteria, fungi, and yeasts. A sterility result is binary in reporting, pass or fail, but statistical underneath, because no test can examine an entire lot without consuming it. The test examines a representative sample and, from that, supports a conclusion about the batch.
This is worth understanding plainly: sterility testing provides strong evidence, not metaphysical certainty. That is why manufacturing controls (clean environments, filtration, validated processes) matter alongside the final test. The test confirms the outcome; the process produces it.
how the USP <71> method works
The compendial sterility test defines two approaches. The preferred one is membrane filtration: the sample is dissolved and passed through a filter fine enough to trap microorganisms, the filter is rinsed, and it is then transferred into growth media. Filtration is preferred because it separates the microorganisms from any component of the sample that might inhibit their growth. The alternative, direct inoculation, transfers the sample straight into the media and is used when filtration is impractical.
Either way, the material is incubated in two media chosen to catch a broad range of organisms:
| Medium | Targets | Typical incubation |
|---|---|---|
| Fluid thioglycollate medium (FTM) | Anaerobic and aerobic bacteria | ~30 to 35 °C |
| Soybean-casein digest medium (SCDM / TSB) | Fungi, yeasts, and aerobic bacteria | ~20 to 25 °C |
Incubation runs for not less than 14 days. Growth (turbidity) in either medium is a fail; no growth across the full period is a pass. Proper testing also runs controls to confirm the media support growth and that the sample itself is not suppressing it.
sterility is not the same as endotoxin (or bioburden)
Three related contamination measures get conflated. They are distinct:
| Test | Question it answers |
|---|---|
| Sterility (USP <71>) | Are any viable microorganisms present at all? |
| Endotoxin (USP <85> / <86>) | Is bacterial lipopolysaccharide residue present, even from dead bacteria? |
| Bioburden / microbial enumeration (USP <61>) | How many microorganisms are present (a count, not pass/fail)? |
A sample can be sterile and still carry endotoxin, because endotoxin is a molecular residue that outlasts the bacteria that produced it. For that reason a thorough COA may report both. See endotoxin testing: LAL, rFC, and what EU/mg means.
when sterility appears on a COA, and when it does not
Not every research-grade lyophilized compound is sold as a sterile material, and sterility testing is not always part of the certificate. Whether it belongs depends on the intended research application. A researcher planning work with cell culture or other living systems has different requirements than one performing a purely chemical analysis.
The practical guidance: read the COA for what it actually reports rather than assuming. If sterility matters for your work and the certificate does not address it, that is a question to ask the supplier before proceeding, not an assumption to make. Storage and handling after the material arrives also affect whether it stays uncontaminated, covered in storing and handling lyophilized research peptides. For how sterility fits with every other parameter, see the pillar guide, reading a Certificate of Analysis.
frequently asked questions
What is USP <71>?
USP General Chapter <71> is the compendial sterility test. It specifies how to test a material for viable microorganisms using membrane filtration or direct inoculation into two growth media, incubated for at least 14 days, with growth indicating a fail.
Is sterility testing the same as endotoxin testing?
No. Sterility testing detects living microorganisms. Endotoxin testing detects lipopolysaccharide residue from gram-negative bacteria, which persists after the bacteria die. A sample can pass sterility and still contain endotoxin, so the two are reported separately.
Why does the sterility test take 14 days?
The 14-day incubation gives slow-growing organisms time to become detectable. A shorter window could return a false pass simply because organisms had not yet multiplied enough to produce visible growth.
Does every research peptide need a sterility result?
Not necessarily. Whether sterility testing is appropriate depends on the intended research use. If it matters for a given application and the COA does not report it, that is a question to raise with the supplier.
references
- U.S. Pharmacopeia, General Chapter <71> Sterility Tests. https://www.usp.org/
- U.S. Pharmacopeia, General Chapter <1211> Sterility Assurance. https://www.usp.org/
- U.S. Pharmacopeia, General Chapter <61> Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests. https://www.usp.org/
continue reading
research use only. sold for in-vitro laboratory research.
not for human or animal use.